INTRODUCTIONCutaneous lupus erythematosus (CLE), a group of autoimmune skin diseases characterized by skin eruptions including, but not limited to photosensitivity, malar rash, discoid lupus erythematosus (DLE), and subacute cutaneous lupus…
Read More
INTRODUCTIONCompound PVP-I liniment is a widely used over-the-counter dermatology drug indicated in the treatment of fungal or bacterial infections of the skin or nails, in which each milliliter contained 30…
Read More
INTRODUCTION Hypertrophic scars, those that are raised and confined to the wound margin, and keloidal scars, those that extend beyond the wound margin, are manifestations of abnormal wound healing.1 In…
Read More
INTRODUCTIONDandruff and seborrheic dermatitis (D/SD) affect about half of the general population worldwide.1 SD in the scalp is commonly known as dandruff and is considered the same condition with varying…
Read More
Janus kinase (JAK) inhibitors, which have been used in a range of disease states from rheumatology to gastroenterology, have been finally adopted into dermatology. These agents are rapidly changing the…
Read More
INTRODUCTIONJanus kinase (JAK) proteins are key, evolutionarily conserved mediators of external-to-internal cellular signaling, activated when external cytokines bind to their respective transmembrane receptors, triggering phosphorylation of JAK proteins, then STAT…
Read More
In this issue:Insights on the Impact of Scalp Barrier Condition on Hair HealthScalp health is essential for healthy hair growth and may be affected by intrinsic or extrinsic factors. Reactive…
Read More
INTRODUCTIONResearch has shown that scalp and hair health are connected, but the link is not yet fully understood or characterized. Hair growth begins within the hair follicle, about 4 mm…
Read More
INTRODUCTIONLaser resurfacing has been the gold standard for the rejuvenation of photodamaged skin over the past four decades.1-4 Ablative laser procedures can efficiently address signs of aging by vaporizing the…
Read More
INTRODUCTIONThe topical therapeutic landscape of atopic dermatitis (AD) has entered the "golden age" of drug development. Until now, the landscape was comprised of 3 major mechanistic classes: (1) corticosteroids, calcineurin…
Read More
In this issue:VEHICLES MATTER: DESIGNED FOR PURPOSEThere are several oral JAK formulations available in the United States market. The first topical cream formulation of a JAK inhibitor is ruxolitinib cream…
Read More
INTRODUCTIONAcanthosis nigricans (AN) is a common skin condition marked by hyperpigmented, velvety plaques.1 In the United States, AN has a prevalence of 19.4%2 and disproportionately impacts individuals with skin of…
Read More
